Drug
Shp674
Shp674: highest development phase Phase 2, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| SHP674 NCT04067518 | Phase 2 | Acute Lymphoblastic Leukemia |
Latest
No recent events.
Follow Shp674 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.